Astex Pharmaceuticals To Present At RBC Capital Markets Healthcare Conference

DUBLIN, Calif., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that Mohammad Azab, MD, chief medical officer, and Michael Molkentin, chief financial officer, will present at the 2013 RBC Capital Markets Healthcare Conference on Wednesday, February 27 th in New York City.

The Company's presentation will begin at 8:00 a.m. ET. A live webcast of the presentation will be available in the Investor Events section of the Company's website, The webcast will be archived for 30 days.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed DACOGEN® (decitabine) for Injection and receives significant royalties on global sales.

For more information about Astex Pharmaceuticals, Inc., please visit

The Astex Pharmaceuticals, Inc. logo is available at
CONTACT: Timothy L. Enns         Astex Pharmaceuticals, Inc.         Senior Vice President          Corporate Communications & Marketing         Tel:  +1 (925) 560-2810         E-mail:         Susanna Chau         Astex Pharmaceuticals, Inc.         Manager         Investor Relations         Tel:  +1 (925) 560-2845         E-mail:         Alan Roemer         The Trout Group         Managing Director         Tel:  +1 (646) 378-2945         E-mail:

Astex Pharmaceuticals, Inc. logo